MENU
LYRA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lyra Therapeutics (LYRA) Ownership - Who owns Lyra Therapeutics?
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients... Show more
Profile
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.27M
P/E Ratio
N/A
Total Cash
31.74M
Projected Growth
N/A
Total Debt
33.36M
Revenue
1.19M
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash/Share
23.94
Total Debt/Equity
N/A
Revenue/Share
0.90 USD as % of share price
Fundamentals
LYRA
Capitalization
12.3M
P/E Ratio
N/A
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash
31.7M
Total Cash/Share
23.94
Total Debt
33.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.90%
Revenue
1.19M
ROE
N/A
Book Value
3.87M
P/B Ratio
3.12
Cash Flow
N/A
Earnings
-60.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
66K
Current Ratio
2.96
Current Revenue Per Employee
6100.00
Dividends Per Share - Security
N/A
EBITDA
-44.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-80.40
Shares Held By Institutions
4.08M
Shares Outstanding - Current
1.33M
Total Liabilities
52.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-11.725
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com